APA (7th ed.) Citation

Moldvay, J., Sapi, Z., Egri, G., Gyulai, M., Szende, B., Losonczy, G., . . . Papay, J. (2009). 62P PLATINUM-BASED CHEMOTHERAPY IN LUNG CANCER AFFECTS THE EXPRESSION OF CERTAIN BIOMARKERS INCLUDING ERCC. Lung Cancer (01695002), 64, S31. https://doi.org/10.1016/S0169-5002(09)70185-0

Chicago Style (17th ed.) Citation

Moldvay, J., Z. Sapi, G. Egri, M. Gyulai, B. Szende, G. Losonczy, J. Timar, and J. Papay. "62P PLATINUM-BASED CHEMOTHERAPY IN LUNG CANCER AFFECTS THE EXPRESSION OF CERTAIN BIOMARKERS INCLUDING ERCC." Lung Cancer (01695002) 64 (2009): S31. https://doi.org/10.1016/S0169-5002(09)70185-0.

MLA (9th ed.) Citation

Moldvay, J., et al. "62P PLATINUM-BASED CHEMOTHERAPY IN LUNG CANCER AFFECTS THE EXPRESSION OF CERTAIN BIOMARKERS INCLUDING ERCC." Lung Cancer (01695002), vol. 64, 2009, p. S31, https://doi.org/10.1016/S0169-5002(09)70185-0.